RU2627420C2 - Мягкие жвачки, не содержащие крахмала - Google Patents

Мягкие жвачки, не содержащие крахмала Download PDF

Info

Publication number
RU2627420C2
RU2627420C2 RU2013120907A RU2013120907A RU2627420C2 RU 2627420 C2 RU2627420 C2 RU 2627420C2 RU 2013120907 A RU2013120907 A RU 2013120907A RU 2013120907 A RU2013120907 A RU 2013120907A RU 2627420 C2 RU2627420 C2 RU 2627420C2
Authority
RU
Russia
Prior art keywords
chewing gum
soft
soft chewing
gum
weight
Prior art date
Application number
RU2013120907A
Other languages
English (en)
Russian (ru)
Other versions
RU2013120907A (ru
Inventor
Каниканти ВЕНКАТА-РАНГАРАО
Ханс-Йюрген ХАМАНН
Original Assignee
Байер Интеллектчуал Проперти Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Байер Интеллектчуал Проперти Гмбх filed Critical Байер Интеллектчуал Проперти Гмбх
Publication of RU2013120907A publication Critical patent/RU2013120907A/ru
Application granted granted Critical
Publication of RU2627420C2 publication Critical patent/RU2627420C2/ru

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Confectionery (AREA)
RU2013120907A 2010-10-12 2011-10-11 Мягкие жвачки, не содержащие крахмала RU2627420C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39215010P 2010-10-12 2010-10-12
US61/392,150 2010-10-12
PCT/EP2011/067699 WO2012049156A1 (en) 2010-10-12 2011-10-11 Non-starch based soft chewables

Publications (2)

Publication Number Publication Date
RU2013120907A RU2013120907A (ru) 2014-11-20
RU2627420C2 true RU2627420C2 (ru) 2017-08-08

Family

ID=45065865

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2013120907A RU2627420C2 (ru) 2010-10-12 2011-10-11 Мягкие жвачки, не содержащие крахмала

Country Status (11)

Country Link
US (1) US9744127B2 (enExample)
EP (1) EP2627314B1 (enExample)
JP (2) JP2013539772A (enExample)
CN (1) CN103200930A (enExample)
AU (1) AU2011315555B2 (enExample)
BR (1) BR112013008834B1 (enExample)
CA (1) CA2814082A1 (enExample)
ES (1) ES2806256T3 (enExample)
MX (1) MX2013003684A (enExample)
RU (1) RU2627420C2 (enExample)
WO (1) WO2012049156A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2755498T3 (en) 2011-09-15 2018-05-22 Friulchem Spa COMPOSITION FOR ORAL ADMINISTRATION FOR ANIMALS AND PROCEDURE FOR OBTAINING
SG11201404595TA (en) 2012-02-06 2014-09-26 Merial Ltd Parasiticidal oral veterinary compositions comprising systemically-acting active agents, methods and uses thereof
BR112014024832B1 (pt) * 2012-04-04 2022-05-31 Intervet International B.V. Método para a preparação de uma composição farmacêutica veterinária mastigável macia, composição farmacêutica, e, uso da composição
CA2883139C (fr) 2012-08-31 2021-08-10 Friulchem Spa Compositions pour administration orale aux animaux, leurs procedes d'obtention et leurs utilisations
MY175703A (en) * 2012-12-19 2020-07-06 Bayer Animal Health Gmbh Tablets with improved acceptance and good storage stability
US9808010B2 (en) 2015-07-06 2017-11-07 Virbac Corporation Chewable composition
US10844154B2 (en) 2015-11-20 2020-11-24 Isp Investments Llc Proliferous copolymers comprising lactamic moieties
BR112018073220A2 (pt) * 2016-05-12 2019-02-19 Bayer Animal Health Gmbh processo para preparar artigos conformados para administração a animais
CA3049952A1 (en) * 2017-07-26 2019-01-31 Tgx Soft Chew, Llc Starch-free soft chew for veterinary applications
WO2019034763A1 (en) 2017-08-17 2019-02-21 Ceva Sante Animale ORAL COMPOSITIONS AND METHODS OF PREPARATION
TW202122077A (zh) * 2019-09-06 2021-06-16 美商拜耳保健責任有限公司 適口軟咀嚼物
EP3878436A1 (en) * 2020-03-09 2021-09-15 Bayer Animal Health GmbH Soft chewable formed body for the administration to animals
JP7403001B2 (ja) * 2020-05-06 2023-12-21 マース インコーポレーテッド 医薬品の投与のための嗜好性支持体組成物
CA3191671A1 (en) * 2020-09-04 2022-03-10 Elanco Us Inc. Palatable formulations
FR3138315A1 (fr) 2022-07-27 2024-02-02 Virbac Produit à usage vétérinaire et procédé pour sa fabrication
PE20231574A1 (es) * 2023-02-24 2023-10-04 Agrovet Market S A Composicion farmaceutica que comprende fluralaner, moxidectina y praziquantel para el tratamiento de infestaciones parasitarias en animales menores

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004016252A1 (en) * 2002-08-16 2004-02-26 Merial Limited Non-animal product containing veterinary formulations
WO2005062782A2 (en) * 2003-12-23 2005-07-14 Merial Limited Non-animal product containing veterinary formulations
WO2008030469A2 (en) * 2006-09-07 2008-03-13 Merial Limited Soft chewable, tablet, and long-acting injectable veterinary antibiotic formulations

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5746986A (en) 1980-09-02 1982-03-17 Dai Ichi Seiyaku Co Ltd Pyrido(1,2,3-de)(1,4)benzoxazine derivative
US4670444B1 (en) 1980-09-03 1999-02-09 Bayer Ag and-naphthyridine-3-carboxylic acids and antibacte7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-quinoline-rial agents containing these compounds
US4472405A (en) 1982-11-12 1984-09-18 Riker Laboratories, Inc. Antimicrobial 6,7-dihydro-5,8-dimethyl-9 fluoro-1-oxo-1H, 5H-benzo (ij) quinolizine-2-carboxylic acid and derivatives
US4730000A (en) 1984-04-09 1988-03-08 Abbott Laboratories Quinoline antibacterial compounds
AT392789B (de) 1985-01-23 1991-06-10 Toyama Chemical Co Ltd Verfahren zur herstellung von 1-substituierten aryl-1,4-dihydro-4-oxonaphthyridinderivaten
IN166416B (enExample) 1985-09-18 1990-05-05 Pfizer
JPH0479844A (ja) * 1990-07-20 1992-03-13 Ajinomoto Co Inc 反芻動物用飼料添加剤
GB9224855D0 (en) * 1992-11-27 1993-01-13 Smithkline Beecham Plc Pharmaceutical compositions
FR2710637B1 (fr) 1993-09-28 1995-12-08 Roquette Freres Mannitol pulvérulent de friabilité modérée et son procédé de préparation.
GB9508443D0 (en) 1995-04-26 1995-06-14 Gilbertson & Page Biscuit for working racing or sporting dogs
DE19520275A1 (de) 1995-06-02 1996-12-05 Bayer Ag Endoparasitizide Mittel
US5904937A (en) * 1997-10-03 1999-05-18 Fmc Corporation Taste masked pharmaceutical compositions
DE10031044A1 (de) 2000-06-26 2002-01-03 Bayer Ag Endoparasitizide Mittel zur freiwilligen oralen Aufnahme durch Tiere
US20060141009A1 (en) 2002-08-13 2006-06-29 Sebastien Huron Novel compositions and processes for delivering an additive
US9561182B2 (en) * 2003-08-22 2017-02-07 Cure Pharmaceutical Corporation Edible films for administration of medicaments to animals, methods for their manufacture and methods for their use for the treatment of animals
US20060233873A1 (en) 2003-01-24 2006-10-19 Julien Meissonnier Dispersion of taste masked crystals or granules of active substances, chewable soft capsules filled with said dispersion, and process for preparing same
EP1641440B1 (en) * 2003-06-25 2010-06-23 Novartis AG Tablet comprising fluvastatin and carmellose calcium
AR045142A1 (es) 2003-07-30 2005-10-19 Novartis Ag Composicion veterinaria masticable ductil de buen sabor
US20070128251A1 (en) * 2005-12-07 2007-06-07 Piedmont Pharmaceuticals, Inc. Process for manufacturing chewable dosage forms for drug delivery and products thereof
US7955632B2 (en) * 2005-12-07 2011-06-07 Bayer B.V. Process for manufacturing chewable dosage forms for drug delivery and products thereof
AU2008247327B2 (en) * 2007-05-07 2013-08-22 Jurox Pty Ltd Improved dosage form and process

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004016252A1 (en) * 2002-08-16 2004-02-26 Merial Limited Non-animal product containing veterinary formulations
WO2005062782A2 (en) * 2003-12-23 2005-07-14 Merial Limited Non-animal product containing veterinary formulations
WO2008030469A2 (en) * 2006-09-07 2008-03-13 Merial Limited Soft chewable, tablet, and long-acting injectable veterinary antibiotic formulations

Also Published As

Publication number Publication date
CA2814082A1 (en) 2012-04-19
BR112013008834B1 (pt) 2021-08-03
EP2627314A1 (en) 2013-08-21
BR112013008834A2 (pt) 2016-06-28
EP2627314B1 (en) 2020-05-06
ES2806256T3 (es) 2021-02-17
MX2013003684A (es) 2013-05-31
US20130197006A1 (en) 2013-08-01
AU2011315555B2 (en) 2016-03-10
JP6200548B2 (ja) 2017-09-20
WO2012049156A1 (en) 2012-04-19
US9744127B2 (en) 2017-08-29
JP2013539772A (ja) 2013-10-28
CN103200930A (zh) 2013-07-10
RU2013120907A (ru) 2014-11-20
JP2016175936A (ja) 2016-10-06
AU2011315555A1 (en) 2013-05-02

Similar Documents

Publication Publication Date Title
RU2627420C2 (ru) Мягкие жвачки, не содержащие крахмала
US8628794B2 (en) Palatable ductile chewable veterinary composition
US11147764B2 (en) Tablets with improved acceptance and good storage stability
TW201806582A (zh) 製備用於投予動物之成形物件的方法
RU2799052C1 (ru) Таблетки с улучшенным приёмом и хорошей устойчивостью при хранении
HK1186983A (en) Non-starch based soft chewables

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20181012